Skip to content

A Simple Comparison of Manjishthadi paste and Lodhradi Paste for Mukhdushika (Acne)

Comparative Efficacy of Manjishthadi Lepa with Lodhradi Lepa in the Management of Mukhdushika with special reference to Acne Vulgaris: A Randomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104280
Enrollment
100
Registered
2026-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Kanchan Rustumrao Bagal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants with classical sign and symptoms of Mukhdushika associated withSkin rash or lesion, Redness (Erythema) of the skin, Inflammation around theskin. 2. Participants having grades 1 to 3. 3. Participants in the age group of 16 to 35 years irrespective of Gender, Religion, and Socio-economic status. 4. Participants willing to take part in the study with informed consent.

Exclusion criteria

Exclusion criteria: 1. Participants diagnosed with systemic and metabolic disorders will be excluded. 2. Those suffering from other skin infections and hypersensitivity of skin. 3. Participants of grade 4 and 5. 4. Participants on any other medication for same disease during study will be excluded. 5. Pregnant women and lactating mothers. 6. Participants having PCOS are excluded.

Design outcomes

Primary

MeasureTime frame
Change in Acne Severity Score (Composite score of Pidika, Daha, Kandu, Ruja, and Strava) from Baseline to Day 30.Timepoint: 45 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Sachin Banarase

Dr Rajendra Gode Ayurveda college hospital and research center Amravati 444602

kanchanbagal03923@gmail.com7218490183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026